A randomized, double-blind, placebo-controlled, multi-center trial of the engineered human anti body to TNF (CDP571) for steroid sparing and maintenance of remission in patients with steroid-dependent Crohn's disease

作者: Brian G. Feagan , William J. Sandborn , J.P. Baker , F. Cominelli , Lloyd R. Sutherland

DOI: 10.1016/S0016-5085(00)84761-7

关键词:

摘要:

参考文章(0)